INKT MiNK Therapeutics, Inc.: institutional ownership and insider trading
27 funds reported holding $3.14M of MiNK Therapeutics, Inc. in their latest 13F filings; in Q2 2026 funds net bought $907K, with 7 new positions and 3 funds selling out; over the last 12 months insiders bought $0 and sold $120K on the open market.
Famous investors holding INKT
- Ken Griffin (Citadel Advisors): $180K, 0.0% of the portfolio
Largest institutional holders of INKT
- VANGUARD CAPITAL MANAGEMENT LLC — $803K
- VANGUARD GROUP INC — $754K
- DnB Asset Management AS — $645K
- Longbow Finance SA — $195K
- GEODE CAPITAL MANAGEMENT, LLC — $182K
- CITADEL ADVISORS LLC — $180K
- BlackRock, Inc. (BLK) — $156K
- VANGUARD FIDUCIARY TRUST CO — $96.9K
- UBS Group AG (UBS) — $57.1K
- Steward Partners Investment Advisory, LLC — $23.4K
Recent INKT insider trades
- Oct 12, 2026: Buell Jennifer sold 6,938 shares ($73.3K)
- Jun 4, 2026: Ryan Barbara sold 1,500 shares ($19.1K)
- Mar 10, 2026: Ryan Barbara sold 1,500 shares ($22.1K)
- Mar 2, 2026: Ryan Barbara sold 500 shares ($5.43K)